Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$250

Avg closing price
Price range

2 Ken Fisher Aspire Biopharma Holdings Trades

Ken Fisher started to build up the position in Aspire Biopharma Holdings in Q4 2025. Since then they sold 6 shares. The investor sold all their shares in Q1 2026 and doesn't own any shares in Aspire Biopharma Holdings anymore.

Avg closing price
Price range
Sold -6 shares Q1 2026
Avg closing price $53.26
Price range $19.72 - $164.40
New holding (+6 shares) Q4 2025
Avg closing price $250.16
Price range $102.00 - $534.00

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!